NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,960,000 | +4.7% | 1,000,000 | 0.0% | 0.58% | +37.2% |
| Q2 2021 | $17,160,000 | -14.2% | 1,000,000 | 0.0% | 0.42% | -3.6% |
| Q1 2021 | $20,000,000 | +198.3% | 1,000,000 | +222.0% | 0.44% | +123.9% |
| Q4 2019 | $6,704,000 | -94.7% | 310,579 | -74.0% | 0.20% | -97.2% |
| Q1 2018 | $126,694,000 | +15.7% | 1,192,300 | -35.0% | 7.00% | +26.8% |
| Q4 2017 | $109,526,000 | +291.4% | 1,834,000 | +57.3% | 5.52% | +333.7% |
| Q3 2017 | $27,986,000 | +22.8% | 1,166,100 | 0.0% | 1.27% | +4.3% |
| Q2 2017 | $22,797,000 | +45.9% | 1,166,100 | +75.2% | 1.22% | +19.1% |
| Q1 2017 | $15,622,000 | +58.9% | 665,600 | +16.3% | 1.02% | +18.0% |
| Q3 2016 | $9,829,000 | +36.4% | 572,100 | -12.7% | 0.87% | -5.1% |
| Q1 2015 | $7,205,000 | -29.0% | 655,000 | 0.0% | 0.92% | -7.9% |
| Q4 2014 | $10,153,000 | – | 655,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |